1887

Journal of General Virology header logo

Volume 95, Issue 3

Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease Free

Abstract

The emerging Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe pulmonary disease in humans and represents the second example of a highly pathogenic coronavirus (CoV) following severe acute respiratory syndrome coronavirus (SARS-CoV). Genomic studies revealed that two viral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), process the polyproteins encoded by the MERS-CoV genomic RNA. We previously reported that SARS-CoV PLpro acts as both deubiquitinase (DUB) and IFN antagonist, but the function of the MERS-CoV PLpro was poorly understood. In this study, we characterized MERS-CoV PLpro, which is a protease and can recognize and process the cleavage sites (CS) of nsp1-2, nsp2-3 and nsp3-4. The LXGG consensus cleavage sites in the N terminus of pp1a/1ab, which is generally essential for CoV PLpro-mediated processing, were also characterized in MERS-CoV. MERS-CoV PLpro, like human SARS-CoV PLpro and NL63-CoV PLP2, is a viral deubiquitinating enzyme. It acts on both K48- and K63-linked ubiquitination and ISG15-linked ISGylation. We confirmed that MERS-CoV PLpro acts as an IFN antagonist through blocking the phosphorylation and nuclear translocation of IFN regulatory factor 3 (IRF3). These findings indicate that MERS-CoV PLpro acts as a viral DUB and suppresses production of IFN-β by an interfering IRF3-mediated signalling pathway, in addition to recognizing and processing the CS at the N terminus of replicase polyprotein to release the non-structural proteins. The characterization of proteolytic processing, DUB and IFN antagonist activities of MERS-CoV PLpro would reveal the interactions between MERS-CoV and its host, and be applicable to develop strategies targeting PLpro for the effective control of MERS-CoV infection.

  • Received:
  • Accepted:
  • Published Online:
© 2014 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.059014-0
2014-03-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/3/614.html?itemId=/content/journal/jgv/10.1099/vir.0.059014-0&mimeType=html&fmt=ahah

References

  1. Anderson L. J., Baric R. S. 2012; Emerging human coronaviruses–disease potential and preparedness. N Engl J Med 367:1850–1852 [View Article][PubMed]
     [Google Scholar]
  2. Assiri A., McGeer A., Perl T. M., Price C. S., Al Rabeeah A. A., Cummings D. A., Alabdullatif Z. N., Assad M., Almulhim A.other authors 2013; Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369:407–416 [View Article][PubMed]
     [Google Scholar]
  3. Barber G. N. 2011; Cytoplasmic DNA innate immune pathways. Immunol Rev 243:99–108 [View Article][PubMed]
     [Google Scholar]
  4. Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A. D., Baker S. C. 2005; The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 79:15189–15198 [View Article][PubMed]
     [Google Scholar]
  5. Booth C. M., Stewart T. E. 2005; Severe acute respiratory syndrome and critical care medicine: the Toronto experience. Crit Care Med 33:SupplS53–S60 [View Article][PubMed]
     [Google Scholar]
  6. Chan J. F., Li K. S., To K. K., Cheng V. C., Chen H., Yuen K. Y. 2012; Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?. J Infect 65:477–489 [View Article][PubMed]
     [Google Scholar]
  7. Chan R. W., Chan M. C., Agnihothram S., Chan L. L., Kuok D. I., Fong J. H., Guan Y., Poon L. L., Baric R. S.other authors 2013; Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol 87:6604–6614 [View Article][PubMed]
     [Google Scholar]
  8. Chan-Yeung M., Xu R. H. 2003; SARS: epidemiology. Respirology 8:SupplS9–S14 [View Article][PubMed]
     [Google Scholar]
  9. Chen Z., Wang Y., Ratia K., Mesecar A. D., Wilkinson K. D., Baker S. C. 2007; Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. J Virol 81:6007–6018 [View Article][PubMed]
     [Google Scholar]
  10. Chen Z., Zhou X., Lunney J. K., Lawson S., Sun Z., Brown E., Christopher-Hennings J., Knudsen D., Nelson E., Fang Y. 2010; Immunodominant epitopes in nsp2 of porcine reproductive and respiratory syndrome virus are dispensable for replication, but play an important role in modulation of the host immune response. J Gen Virol 91:1047–1057 [View Article][PubMed]
     [Google Scholar]
  11. Clementz M. A., Chen Z., Banach B. S., Wang Y., Sun L., Ratia K., Baez-Santos Y. M., Wang J., Takayama J.other authors 2010; Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 84:4619–4629 [View Article][PubMed]
     [Google Scholar]
  12. Coornaert B., Carpentier I., Beyaert R. 2009; A20: central gatekeeper in inflammation and immunity. J Biol Chem 284:8217–8221 [View Article][PubMed]
     [Google Scholar]
  13. de Groot R. J., Baker S. C., Baric R. S., Brown C. S., Drosten C., Enjuanes L., Fouchier R. A., Galiano M., Gorbalenya A. E.other authors 2013; Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 87:7790–7792 [View Article][PubMed]
     [Google Scholar]
  14. Dev A., Iyer S., Razani B., Cheng G. 2011; NF-κB and innate immunity. Curr Top Microbiol Immunol 349:115–143[PubMed]
     [Google Scholar]
  15. Devaraj S. G., Wang N., Chen Z., Chen Z., Tseng M., Barretto N., Lin R., Peters C. J., Tseng C. T.other authors 2007; Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem 282:32208–32221 [View Article][PubMed]
     [Google Scholar]
  16. Evans P. C., Ovaa H., Hamon M., Kilshaw P. J., Hamm S., Bauer S., Ploegh H. L., Smith T. S. 2004; Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 378:727–734 [View Article][PubMed]
     [Google Scholar]
  17. Frieman M., Ratia K., Johnston R. E., Mesecar A. D., Baric R. S. 2009; Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol 83:6689–6705 [View Article][PubMed]
     [Google Scholar]
  18. Gosert R., Kanjanahaluethai A., Egger D., Bienz K., Baker S. C. 2002; RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol 76:3697–3708 [View Article][PubMed]
     [Google Scholar]
  19. Harcourt B. H., Jukneliene D., Kanjanahaluethai A., Bechill J., Severson K. M., Smith C. M., Rota P. A., Baker S. C. 2004; Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol 78:13600–13612 [View Article][PubMed]
     [Google Scholar]
  20. Kanjanahaluethai A., Jukneliene D., Baker S. C. 2003; Identification of the murine coronavirus MP1 cleavage site recognized by papain-like proteinase 2. J Virol 77:7376–7382 [View Article][PubMed]
     [Google Scholar]
  21. Kanjanahaluethai A., Chen Z., Jukneliene D., Baker S. C. 2007; Membrane topology of murine coronavirus replicase nonstructural protein 3. Virology 361:391–401 [View Article][PubMed]
     [Google Scholar]
  22. Katz E. J., Isasa M., Crosas B. 2010; A new map to understand deubiquitination. Biochem Soc Trans 38:21–28 [View Article][PubMed]
     [Google Scholar]
  23. Kayagaki N., Phung Q., Chan S., Chaudhari R., Quan C., O’Rourke K. M., Eby M., Pietras E., Cheng G.other authors 2007; DUBA: a deubiquitinase that regulates type I interferon production. Science 318:1628–1632 [View Article][PubMed]
     [Google Scholar]
  24. Khan G. 2013; A novel coronavirus capable of lethal human infections: an emerging picture. Virol J 10:66 [View Article][PubMed]
     [Google Scholar]
  25. Kiefer F., Arnold K., Künzli M., Bordoli L., Schwede T. 2009; The swiss-model repository and associated resources. Nucleic Acids Res 37:DatabaseD387–D392 [View Article][PubMed]
     [Google Scholar]
  26. Kilianski A., Mielech A., Deng X., Baker S. C. 2013; Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J Virol 87:11955–11962 [View Article][PubMed]
     [Google Scholar]
  27. Kim J. C., Spence R. A., Currier P. F., Lu X., Denison M. R. 1995; Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d. Virology 208:1–8 [View Article][PubMed]
     [Google Scholar]
  28. Kim E. T., Oh S. E., Lee Y. O., Gibson W., Ahn J. H. 2009; Cleavage specificity of the UL48 deubiquitinating protease activity of human cytomegalovirus and the growth of an active-site mutant virus in cultured cells. J Virol 83:12046–12056 [View Article][PubMed]
     [Google Scholar]
  29. Kindler E., Jónsdóttir H. R., Muth D., Hamming O. J., Hartmann R., Rodriguez R., Geffers R., Fouchier R. A., Drosten C.other authors 2013; Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio 4:e00611–e00612 [View Article][PubMed]
     [Google Scholar]
  30. Lau S. K., Li K. S., Tsang A. K., Lam C. S., Ahmed S., Chen H., Chan K. H., Woo P. C., Yuen K. Y. 2013; Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87:8638–8650 [View Article][PubMed]
     [Google Scholar]
  31. Lim K. P., Ng L. F., Liu D. X. 2000; Identification of a novel cleavage activity of the first papain-like proteinase domain encoded by open reading frame 1a of the coronavirus Avian infectious bronchitis virus and characterization of the cleavage products. J Virol 74:1674–1685 [View Article][PubMed]
     [Google Scholar]
  32. Lindner H. A., Lytvyn V., Qi H., Lachance P., Ziomek E., Ménard R. 2007; Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch Biochem Biophys 466:8–14 [View Article][PubMed]
     [Google Scholar]
  33. Ma A., Malynn B. A. 2012; A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol 12:774–785 [View Article][PubMed]
     [Google Scholar]
  34. Marsili G., Remoli A. L., Sgarbanti M., Perrotti E., Fragale A., Battistini A. 2012; HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion. Cytokine Growth Factor Rev 23:255–270 [View Article][PubMed]
     [Google Scholar]
  35. Oostra M., Hagemeijer M. C., van Gent M., Bekker C. P., te Lintelo E. G., Rottier P. J., de Haan C. A. 2008; Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol 82:12392–12405 [View Article][PubMed]
     [Google Scholar]
  36. Prentice E., Jerome W. G., Yoshimori T., Mizushima N., Denison M. R. 2004; Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem 279:10136–10141 [View Article][PubMed]
     [Google Scholar]
  37. Ratia K., Saikatendu K. S., Santarsiero B. D., Barretto N., Baker S. C., Stevens R. C., Mesecar A. D. 2006; Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci U S A 103:5717–5722 [View Article][PubMed]
     [Google Scholar]
  38. Reyes-Turcu F. E., Ventii K. H., Wilkinson K. D. 2009; Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78:363–397 [View Article][PubMed]
     [Google Scholar]
  39. Sawicki S. G., Sawicki D. L., Younker D., Meyer Y., Thiel V., Stokes H., Siddell S. G. 2005; Functional and genetic analysis of coronavirus replicase-transcriptase proteins. PLoS Pathog 1:e39 [View Article][PubMed]
     [Google Scholar]
  40. Snijder E. J., van der Meer Y., Zevenhoven-Dobbe J., Onderwater J. J., van der Meulen J., Koerten H. K., Mommaas A. M. 2006; Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80:5927–5940 [View Article][PubMed]
     [Google Scholar]
  41. Sulea T., Lindner H. A., Purisima E. O., Ménard R. 2005; Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease?. J Virol 79:4550–4551 [View Article][PubMed]
     [Google Scholar]
  42. Sulea T., Lindner H. A., Purisima E. O., Ménard R. 2006; Binding site-based classification of coronaviral papain-like proteases. Proteins 62:760–775 [View Article][PubMed]
     [Google Scholar]
  43. Sun S. C. 2008; Deubiquitylation and regulation of the immune response. Nat Rev Immunol 8:501–511 [View Article][PubMed]
     [Google Scholar]
  44. Sun S. C. 2010; CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ 17:25–34 [View Article][PubMed]
     [Google Scholar]
  45. Sun L., Yang Y., Liu D., Xing Y., Chen X., Chen Z. 2010; Deubiquitinase activity and regulation of antiviral innate immune responses by papain-like proteases of human coronavirus NL63. Prog Biochem Biophys 37:871–880 [View Article]
     [Google Scholar]
  46. Sun L., Xing Y., Chen X., Zheng Y., Yang Y., Nichols D. B., Clementz M. A., Banach B. S., Li K.other authors 2012; Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS ONE 7:e30802 [View Article][PubMed]
     [Google Scholar]
  47. van Boheemen S., de Graaf M., Lauber C., Bestebroer T. M., Raj V. S., Zaki A. M., Osterhaus A. D., Haagmans B. L., Gorbalenya A. E.other authors 2012; Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3:e00473-e12 [View Article][PubMed]
     [Google Scholar]
  48. van der Veen A. G., Ploegh H. L. 2012; Ubiquitin-like proteins. Annu Rev Biochem 81:323–357 [View Article][PubMed]
     [Google Scholar]
  49. Vaux D. L., Fidler F., Cumming G. 2012; Replicates and repeats –what is the difference and is it significant? A brief discussion of statistics and experimental design. EMBO Rep 13:291–296 [View Article][PubMed]
     [Google Scholar]
  50. Wang D., Fang L., Li P., Sun L., Fan J., Zhang Q., Luo R., Liu X., Li K.other authors 2011; The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol 85:3758–3766 [View Article][PubMed]
     [Google Scholar]
  51. Xing Y., Chen J., Tu J., Zhang B., Chen X., Shi H., Baker S. C., Feng L., Chen Z. 2013; The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. J Gen Virol 94:1554–1567 [View Article][PubMed]
     [Google Scholar]
  52. Zaki A. M., van Boheemen S., Bestebroer T. M., Osterhaus A. D., Fouchier R. A. 2012; Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820 [View Article][PubMed]
     [Google Scholar]
  53. Zhao C., Denison C., Huibregtse J. M., Gygi S., Krug R. M. 2005; Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102:10200–10205 [View Article][PubMed]
     [Google Scholar]
  54. Zheng L., Baumann U., Reymond J. L. 2004; An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res 32:e115 [View Article][PubMed]
     [Google Scholar]
  55. Ziebuhr J., Schelle B., Karl N., Minskaia E., Bayer S., Siddell S. G., Gorbalenya A. E., Thiel V. 2007; Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication. J Virol 81:3922–3932 [View Article][PubMed]
     [Google Scholar]
  56. Zielecki F., Weber M., Eickmann M., Spiegelberg L., Zaki A. M., Matrosovich M., Becker S., Weber F. 2013; Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol 87:5300–5304 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.059014-0
Loading
Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease
J. Gen. Virol. 95, 614 (2014); https://doi.org/10.1099/vir.0.059014-0
/content/journal/jgv/10.1099/vir.0.059014-0
/content/journal/jgv/10.1099/vir.0.059014-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error